Vadim Shepel

Vadim Shepel is an accomplished professional with extensive experience in venture capital and strategic leadership in the healthcare sector. Currently serving as a Program Mentor at BrightEdge, the innovation arm of the American Cancer Society, Vadim also holds roles as a Network Partner at 2048 Ventures and a Mentor at IndieBio, focusing on early-stage deep tech ventures. As the Founder and CEO of Bench2Bio and former Chief Business and Operating Officer at Concarlo Therapeutics, Vadim demonstrates a strong entrepreneurial spirit. Prior roles include Senior Director at BeiGene, Venture Partner at FundRx, and various strategic positions at Pfizer, contributing to corporate strategy and operational initiatives. Vadim’s early career involved impactful work with the Clinton Health Access Initiative and Sisu Global Health. Educational qualifications include a BS in Economics with a minor in Computer Science from New York University and completion of the Tacklebox Start-Up Accelerator program.